Aktuelles aus der Forschung

Alpha-1 Antitrypsin Deficiency: Home Therapy
Anna Annunziata et al., in Frontiers of Pharmacology, 2021
Download

A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
Natalie McEvoy et al., in Trials, 2021 
Download

​Commercial α1-antitrypsin preparations markedly differ in their potential toinhibit the ATP-induced release of monocytic interleukin-1
A. Agn´e et at., in Pulmonary Pharmacology & Therapeutics, 2021
Download


Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
Nawfal Basil et al., in J Thromb Haemost,. 2021
Download


Comparison of different algorithms in laboratory diagnosis of Alpha1-antitrypsin deficiency
Alice M. Balderacchi et al, Clin Chem Lab Med, 2021
Download

Alpha-1  Antitrypsin  Augmentation Therapy Improves Survival in Severely Deficient Patients with  Pr edicted FEV1  Between 10%  and  60%: A Retrospective Analysis of the  NHLBI Alpha-1 Antitrypsin Deficiency
Franck F Rahaghi et al., in International Journal of Chronic Obstructive Pulmonary Disease, 2020
Download


Improving Screening for Alpha-1 Antitrypsin Deficiency With Direct Testing in the Pulmonary Function Testing  Laboratory  
Samuel Gurevich et al, in Journal of the COPD Foundation, 2021
Download


Consequences of Abrupt Cessation of Alpha 1 - Antitrypsin Replacement Therapy
Oliver McElvaney et. al, in N ENG J MED 382;15, 2020
Download